We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+3.24%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.7B
AUM Growth
+$1.52B
(+4.7%)
Cap. Flow
+$861M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
14.52%
Holding
3,141
New
144
Increased
1,491
Reduced
1,301
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$43.1M |
| 2 |
ExxonMobil
XOM
|
+$33.4M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$27.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.7M |
| 5 |
Johnson & Johnson
JNJ
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$86.8M |
| 2 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$42.6M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$30.6M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$22.1M |
| 5 |
JAH
JARDEN CORPORATION
JAH
|
+$21.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.29% |
| 2 | Financials | 14.18% |
| 3 | Technology | 13.8% |
| 4 | Industrials | 10.4% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
MiMedx Group
MDXG
$636M
| $1.05M | ﹤0.01% |
132,189
-456
| -0.3% | -$3.55K |
|
|
CSR
1752
Centerspace
CSR
$941M
| $1.05M | ﹤0.01% |
16,268
-4,123
| -20% | -$268K |
|
1753
Cavco Industries
CVCO
$4.33B
| $1.05M | ﹤0.01% |
11,209
+658
| +6% | +$60.7K |
|
|
CLDT
1754
Chatham Lodging
CLDT
$622M
| $1.05M | ﹤0.01% |
47,669
-12,182
| -20% | -$260K |
|
|
ELGX
1755
DELISTED
Endologix Inc
ELGX
| $1.05M | ﹤0.01% |
8,413
+808
| +11% | +$92.9K |
|
1756
Supernus Pharmaceuticals
SUPN
$2.65B
| $1.05M | ﹤0.01% |
51,383
+11,485
| +29% | +$204K |
|
1757
SPS Commerce
SPSC
$2.42B
| $1.04M | ﹤0.01% |
34,492
-486
| -1% | -$12.6K |
|
1758
TSMC
TSM
$2.09T
| $1.04M | ﹤0.01% |
39,671
| – | – |
|
1759
Sonic Automotive
SAH
$3.17B
| $1.04M | ﹤0.01% |
60,777
-14,209
| -19% | -$246K |
|
1760
Shutterstock
SSTK
$198M
| $1.04M | ﹤0.01% |
22,713
+4,050
| +22% | +$167K |
|
1761
Diodes
DIOD
$3.77B
| $1.04M | ﹤0.01% |
55,302
-11,860
| -18% | -$225K |
|
1762
Stagwell
STGW
$2.1B
| $1.04M | ﹤0.01% |
56,816
-581
| -1% | -$11.2K |
|
|
CVT
1763
DELISTED
CVENT, INC.
CVT
| $1.04M | ﹤0.01% |
29,077
+7,179
| +33% | +$238K |
|
|
PRAH
1764
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.04M | ﹤0.01% |
24,863
+3,877
| +18% | +$179K |
|
1765
Delek US
DK
$4.15B
| $1.03M | ﹤0.01% |
78,315
+4,067
| +5% | +$57.9K |
|
1766
United Parks & Resorts
PRKS
$2.15B
| $1.03M | ﹤0.01% |
72,149
+5,165
| +8% | +$93.4K |
|
1767
Ubiquiti
UI
$32.3B
| $1.03M | ﹤0.01% |
26,728
-4,015
| -13% | -$149K |
|
|
BOBE
1768
DELISTED
Bob Evans Farms, Inc.
BOBE
| $1.02M | ﹤0.01% |
26,975
-11,229
| -29% | -$503K |
|
|
LCI
1769
DELISTED
Lannett Company, Inc.
LCI
| $1.02M | ﹤0.01% |
10,751
+1,632
| +18% | +$140K |
|
|
MNTA
1770
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.02M | ﹤0.01% |
94,672
+17,864
| +23% | +$184K |
|
1771
Lakeland Financial Corp
LKFN
$1.56B
| $1.02M | ﹤0.01% |
32,525
-8,557
| -21% | -$269K |
|
1772
Manitowoc
MTW
$497M
| $1.02M | ﹤0.01% |
46,648
-57,626
| -55% | -$1.25M |
|
|
CPXX
1773
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $1.02M | ﹤0.01% |
+33,659
| New | +$683K |
|
|
CFNL
1774
DELISTED
Cardinal Financial Corp
CFNL
| $1.02M | ﹤0.01% |
46,301
-9,394
| -17% | -$202K |
|
1775
Alamo Group
ALG
$1.92B
| $1.01M | ﹤0.01% |
15,380
-1,260
| -8% | -$73.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2016 Portfolio in Review
As of Q2 2016, RhumbLine Advisers held 3,141 positions worth $33.7B, up 4.7% from $32.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers's Q2 2016 filing shows 144 new, 1,491 increased, 1,301 reduced and 155 closed positions. Its largest new stake was S&P Global: 401,386 shares worth $43.1M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $86.8M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- RhumbLine Advisers's largest Q2 2016 buy was S&P Global: 401,386 shares worth $43.1M.
- RhumbLine Advisers added most to ExxonMobil in Q2 2016, an estimated $33.4M increase.
- RhumbLine Advisers's biggest Q2 2016 reduction was Coca-Cola Europacific Partners, cutting an estimated $16.1M.
- RhumbLine Advisers fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $86.8M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $33.7B portfolio in Q2 2016.
- RhumbLine Advisers opened 144 new positions and closed 155 in Q2 2016.
- RhumbLine Advisers's portfolio value rose 4.7% quarter-over-quarter to $33.7B.
Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.